Results 31 to 40 of about 62,886 (320)

Medication errors safety signals COVID-19-related Moroccan Pv database [PDF]

E3S Web of Conferences, 2021
On March 23, 2020, the Moroccan Ministry of Health issued a circular authorizing the off label use of hydroxychloroquine or chloroquine in combination with azythromycin as first-line treatment for all COVID-19 patients. The aim of this study is to detect,
Sefiani Houda, Benabdallah Ghita, Tebaa Amina, Soulaymani Bencheikh Rachida   +3 more
doaj   +1 more source

Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France. [PDF]

Fundam Clin Pharmacol
ABSTRACT Background Seizures after the use of cannabinoids are reported, but no precise descriptions of the characteristics of subjects and factors that may trigger seizures are available. Objectives To study the characteristics and circumstances associated with the occurrence of seizures in individuals using cannabinoids for medical or recreational ...
Laroche ML, Labetoulle M, Jouanjus E, Kröger E, Zongo A.   +4 more
europepmc   +2 more sources

Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands [PDF]

, 2006
Objective: Inhaled corticosteroids (ICS) are widely used in the treatment of asthma. We studied the suspected adverse drug reactions (sADRs) reported during the use of ICS in the Netherlands. Methods: In the Netherlands, health professionals and patients
de Jong-van den Berg, L.T.W., de Vries, T.W., Duiverman, E.J., Langen-Wouterse, J.J., van Puijenbroek, E.   +4 more
core   +1 more source

Pharmacovigilance in vaccines

Indian Journal of Pharmacology, 2010
Sir, Vaccines are among the safest tools of modern medicine that help in protecting against disease by inducing immunity. In all countries, routine immunization represents a fundamental service of the public health system, offering one of the most cost-effective methods of reducing morbidity and mortality among children less than five.
Budhiraja, Salil, Akinapelli, Raghuram
openaire   +4 more sources

Need for the Development of Dialectical Thinking in Pharmaceutical Personnel to Improve Their Performance in the Pharmacovigilance System

Безопасность и риск фармакотерапии, 2022
The pharmacovigilance system aimed at ensuring the safety of medicines has been functioning in Russia since 1997. However, at the moment, an important part of this system, pharmacy organisations, is not sufficiently involved in pharmacovigilance ...
A. E. Krasheninnikov, B. K. Romanov, R. S. Safiullin, N. V. Shestakov   +3 more
doaj   +1 more source

The promotion of data sharing in pharmacoepidemiology [PDF]

, 2014
This article addresses the role of pharmacoepidemiology in patient safety and the crucial role of data sharing in ensuring that such activities occur. Against the backdrop of proposed reforms of European data protection legislation, it considers whether ...
Sethi, Nayha
core   +1 more source

Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study

Journal of Pharmaceutical Policy and Practice, 2022
Background Upon the authorization of COVID-19 vaccines worldwide, national and international standards were developed to help integrate mass COVID-19 immunization campaigns into the healthcare network.
Abeer Zeitoun, Souheil Hallit, Maya Helali, Sirine Chehade, Carla Allam, Aya Ibrahim, Hani Dimassi, Rita Karam   +7 more
doaj   +1 more source

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database [PDF]

, 2013
Background: Drug-induced torsades de pointes (TdP) and related clinical entities represent a current regulatory and clinical burden. Objective: As part of the FP7 ARITMO (Arrhythmogenic Potential of Drugs) project, we explored the publicly available US ...
A Bate, A Clarke, A Pariente, AK Chung, Ariola Koci, B Darpo, BJ Drew, C Meyer-Massetti, DM Roden, DW Hough, E Poluzzi, E Poluzzi, E Poluzzi, E Raschi, E Raschi, Edoardo Spina, Elijah R. Behr, Elisabetta Poluzzi, Emanuel Raschi, EP Puijenbroek van, ER Behr, F Ponti De, F Ponti De, F Rani, Fabrizio De Ponti, GC Alexander, GK Isbister, H Verdoux, J Nielsen, J Papay, K Jolly, K Titier, LC Wittkampf, LS Schneider, Miriam Sturkenboom, NP Tatonetti, P Kannankeril, P Manu, P Vigneault, RC Owens Jr, RR Shah, S Dhillon, S Hennessy, S Kongsamut, S Leucht, SM Straus, Ugo Moretti, W Crumb, W Crumb, WA Ray, WA Ray, WJ Crumb Jr, WP Stephenson, Y Suzuki   +53 more
core   +3 more sources

Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees

BMC Medical Ethics, 2021
Background This paper highlights the issues that one of the 90 Italian Research Ethics Committees (RECs) might encounter during the approval phase of a clinical trial to identify corrective and preventive actions for promoting a more efficient review ...
G. Benfatto, Regulatory Group, Ethics Committee Catania 1 (Group), F. Drago   +3 more
doaj   +1 more source

Views of healthcare professionals to linkage of routinely collected healthcare data : a systematic review [PDF]

, 2013
Peer reviewedPublisher ...
Bond, C, Francis, J, Haughney, J, Helms, P J, Hopf, Y M   +4 more
core   +2 more sources